Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● Its low valuation, with P/E ratio at 6.41 and 6.87 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.59 for the 2021 fiscal year.

● The company appears to be poorly valued given its net asset value.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● The opinion of analysts covering the stock has improved over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● The company does not generate enough profits, which is an alarming weak point.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

● The company's earnings releases usually do not meet expectations.